Photo courtesy of Canopius

Canopius welcomes new global head and CEO

He was previously chief executive for reinsurance in AXA XL Bermuda.

Canopius has appointed Charles Cooper as the global head of reinsurance and CEO of Canopius's Bermudian entities. 

Reporting to Canopius Group CEO Neil Robertson and joining the Canopius Group Leadership Team, Charles will assume his new role on 1 September.

Previously serving as Chief Executive for reinsurance in Bermuda at AXA XL, Cooper brings nearly 20 years of experience in the Bermudian reinsurance sector.

He played a role in establishing and implementing a global reinsurance strategy and operating model following AXA's acquisition of XL Group in 2018.

In his new role, Cooper will be responsible for driving Canopius's global reinsurance business strategy, leveraging favourable market conditions. 

ALSO READ: Reinsurer Canopius builds global cyber incident team

He will collaborate with reinsurance professionals in Bermuda, London, and Singapore to further develop the business as a significant growth driver.

Additionally, Cooper will focus on expanding Canopius's Bermuda platform, which received a Class 4 Reinsurer license from the Bermuda Monetary Authority in 2021. 

This licence broadens the business's scope and enhances its ability to capitalise on market opportunities.

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.